Report from a consensus conference on primary graft dysfunction after cardiac transplantation
- PMID: 24661451
- DOI: 10.1016/j.healun.2014.02.027
Report from a consensus conference on primary graft dysfunction after cardiac transplantation
Abstract
Although primary graft dysfunction (PGD) is fairly common early after cardiac transplant, standardized schemes for diagnosis and treatment remain contentious. Most major cardiac transplant centers use different definitions and parameters of cardiac function. Thus, there is difficulty comparing published reports and no agreed protocol for management. A consensus conference was organized to better define, diagnose, and manage PGD. There were 71 participants (transplant cardiologists, surgeons, immunologists and pathologists), with vast clinical and published experience in PGD, representing 42 heart transplant centers worldwide. State-of-the-art PGD presentations occurred with subsequent breakout sessions planned in an attempt to reach consensus on various issues. Graft dysfunction will be classified into primary graft dysfunction (PGD) or secondary graft dysfunction where there is a discernible cause such as hyperacute rejection, pulmonary hypertension, or surgical complications. PGD must be diagnosed within 24 hours of completion of surgery. PGD is divided into PGD-left ventricle and PGD-right ventricle. PGD-left ventricle is categorized into mild, moderate, or severe grades depending on the level of cardiac function and the extent of inotrope and mechanical support required. Agreed risk factors for PGD include donor, recipient, and surgical procedural factors. Recommended management involves minimization of risk factors, gradual increase of inotropes, and use of mechanical circulatory support as needed. Retransplantation may be indicated if risk factors are minimal. With a standardized definition of PGD, there will be more consistent recognition of this phenomenon and treatment modalities will be more comparable. This should lead to better understanding of PGD and prevention/minimization of its adverse outcomes.
Keywords: cardiac transplantation; consensus; outcomes; primary graft dysfunction; primary graft failure.
Copyright © 2014 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.J Heart Lung Transplant. 2018 Dec;37(12):1433-1442. doi: 10.1016/j.healun.2018.07.013. Epub 2018 Jul 26. J Heart Lung Transplant. 2018. PMID: 30206023
-
Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition.Transplantation. 2015 Sep;99(9):1919-25. doi: 10.1097/TP.0000000000000620. Transplantation. 2015. PMID: 25742423 Free PMC article.
-
Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant.Clin Transplant. 2019 May;33(5):e13538. doi: 10.1111/ctr.13538. Epub 2019 Apr 14. Clin Transplant. 2019. PMID: 30870577
-
Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system.J Heart Lung Transplant. 2007 May;26(5):431-6. doi: 10.1016/j.healun.2007.01.029. Epub 2007 Mar 21. J Heart Lung Transplant. 2007. PMID: 17449410 Review.
-
Primary graft dysfunction after liver transplantation.Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):125-37. doi: 10.1016/s1499-3872(14)60023-0. Hepatobiliary Pancreat Dis Int. 2014. PMID: 24686540 Review.
Cited by
-
Experience of ECMO in primary graft dysfunction after orthotopic heart transplantation.Arq Bras Cardiol. 2015 Sep;105(3):285-91. doi: 10.5935/abc.20150082. Epub 2015 Jul 21. Arq Bras Cardiol. 2015. PMID: 26200896 Free PMC article.
-
Associated Clinical and Laboratory Markers of Donor on Allograft Function After Heart Transplant.Braz J Cardiovasc Surg. 2016 Apr;31(2):89-97. doi: 10.5935/1678-9741.20160025. Braz J Cardiovasc Surg. 2016. PMID: 27556306 Free PMC article.
-
Recipient Pericardial Apolipoprotein Levels Might Be an Indicator of Worse Outcomes after Orthotopic Heart Transplantation.Int J Mol Sci. 2024 Feb 1;25(3):1752. doi: 10.3390/ijms25031752. Int J Mol Sci. 2024. PMID: 38339027 Free PMC article.
-
A Discussion on Interpreting Primary Graft Dysfunction Outcomes: Reply.Ann Thorac Surg. 2021 Feb;111(2):735-736. doi: 10.1016/j.athoracsur.2020.07.081. Epub 2020 Oct 20. Ann Thorac Surg. 2021. PMID: 33096074 Free PMC article. No abstract available.
-
Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Heart Transplantation: A 7-Year Experience.Front Med (Lausanne). 2021 Dec 16;8:774644. doi: 10.3389/fmed.2021.774644. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34988094 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous